I am Head of Behavioral Science & Data Science at Sandoz, where I drive the application of behavioral science and data science to drive innovation and efficiency. Behavior has rarely been optimized in large companies. Therefore, there is great potential by applying applied behavioral science to numerous projects in business transformation, sales, compliance and of course human resources. I also run a private blog on behavioral & data science at www.behavioraldesign.de

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access for patients. Our broad global portfolio comprises about 1,500 quality biosimilar and generic medicines. We provide more than 800 million patient treatments per year, generating more than USD 18 billion in direct savings in the US and Europe alone, improving healthcare by freeing up resources and resulting in a total social impact estimated at around USD 400 billion per year worldwide.